Jane Street Group LLC Takes Position in MedEquities Realty Trust Inc (NYSE:MRT)

Jane Street Group LLC purchased a new position in MedEquities Realty Trust Inc (NYSE:MRT) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 23,016 shares of the financial services provider’s stock, valued at approximately $270,000. Jane Street Group LLC owned 0.07% of MedEquities Realty Trust at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MRT. Schwab Charles Investment Management Inc. raised its holdings in MedEquities Realty Trust by 59.0% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 509,750 shares of the financial services provider’s stock worth $6,434,000 after purchasing an additional 189,219 shares during the period. American Century Companies Inc. raised its holdings in MedEquities Realty Trust by 11.2% in the 3rd quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock worth $20,283,000 after purchasing an additional 174,261 shares during the period. State Street Corp raised its holdings in MedEquities Realty Trust by 41.7% in the 2nd quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock worth $6,684,000 after purchasing an additional 155,934 shares during the period. Prudential Financial Inc. raised its holdings in MedEquities Realty Trust by 5.4% in the 3rd quarter. Prudential Financial Inc. now owns 2,658,837 shares of the financial services provider’s stock worth $31,242,000 after purchasing an additional 136,499 shares during the period. Finally, Eagle Boston Investment Management Inc. raised its holdings in MedEquities Realty Trust by 23.7% in the 2nd quarter. Eagle Boston Investment Management Inc. now owns 700,597 shares of the financial services provider’s stock worth $8,841,000 after purchasing an additional 134,095 shares during the period. 93.19% of the stock is owned by institutional investors.

In related news, CEO John W. Mcroberts purchased 18,000 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The stock was purchased at an average price of $10.74 per share, with a total value of $193,320.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Randy L. Churchey purchased 5,300 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The stock was bought at an average cost of $10.87 per share, with a total value of $57,611.00. Following the acquisition, the director now owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 23,600 shares of company stock valued at $254,129. Insiders own 2.50% of the company’s stock.

Shares of MedEquities Realty Trust Inc (NYSE:MRT) traded down $0.17 during trading on Friday, hitting $10.84. The company’s stock had a trading volume of 360,796 shares, compared to its average volume of 300,208. MedEquities Realty Trust Inc has a fifty-two week low of $10.06 and a fifty-two week high of $13.06. The firm has a market capitalization of $344.23 and a PE ratio of 27.79.

A number of equities analysts have commented on MRT shares. ValuEngine raised MedEquities Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, December 1st. Zacks Investment Research cut MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. B. Riley reissued a “buy” rating on shares of MedEquities Realty Trust in a report on Wednesday, November 8th. Capital One Financial reissued an “equal weight” rating on shares of MedEquities Realty Trust in a report on Sunday, October 22nd. Finally, KeyCorp reissued a “buy” rating and set a $13.00 target price on shares of MedEquities Realty Trust in a report on Tuesday, September 26th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $13.00.

TRADEMARK VIOLATION WARNING: “Jane Street Group LLC Takes Position in MedEquities Realty Trust Inc (NYSE:MRT)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/13/jane-street-group-llc-acquires-new-position-in-medequities-realty-trust-inc-mrt.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Institutional Ownership by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply